Home
Welcome Note
Meeting Information
Meeting Chairpersons
Faculty
Abstract Submission
Poster Display Guidelines
CME
General Information
Your arrival to Valencia
Italian Agent
Partners
About Valencia
Program
Scientific Program
Timetable
Registration & Accommodation
Registration
Accommodation
Invitation letter
Sponsorship & Exhibition
Exhibition
Sponsors
Exhibitors
Sponsorship Prospectus
Contact Us
  Scientific Program
Print
THE EMBRYO

Friday, 30 March 2012

09:00-10:15
Chairperson:
SESSION 1: NEW ERA OF MORPHOLOGICAL BIOMARKERS
David Gardner, Australia
09:00-09:15
Course Introduction and Orientation by Meeting Co-Chairperons
Denny Sakkas, USA; Carlos Simón, Spain
09:15-09:45
Clinical relevance of morphokinetics to assess embryo viability
Marcos Meseguer, Spain
09:45-10:15
Correlated time lapse imaging and molecular analysis to assess embryo viability
Sheshua Shen, USA
 
10:15-11:15
Chairperson:
SESSION 2: GENETIC-BASED BIOMARKERS
Alan Handyside
, UK
10:15-10:45
Use of Comparative Genomic Hybridization (CGH) for embryo assessment. Clinical results
Carmen Rubio, Spain
10:45-11:15
 
Four hour 24 chromosome aneuploidy screening and class I evidence of safety, predictive value, and clinical efficacy
Nathan Treff, USA
 
11:15-11:45
Coffee Break
 
11:45-13:15
Chairperson:
SESSION 2 (continued): GENETIC-BASED BIOMARKERS
Alan Handyside
, UK
11:45-12:15
Emerging role for SNP-based technologies for preimplantation genetic screening
Alan Handyside, UK
12:15-12:45
New PGD techniques based on massive sequencing
Julio Martín, Spain
12:45-13:15
Cumulus cells as markers of oocyte and embryo quality
Emre Seli, USA
 
13:15-13:30
Technical Break
 
 
13:30-14:15
LUNCH SYMPOSIUM SPONSORED BY MERCK SERONO 
GRANT FOR FERTILITY INNOVATION: DEVELOPING INNOVATIVE TECHNOLOGIES TO BECOME BEST IN CLASS IN TAKE HOME BABY RATE
Rapid inexpensive DNA fragmentation analysis of sperm & cumulus cells
Dagan Wells
, UK
 
14:15-14:30
Technical Break
   
14:30-16:00
Chairperson:
SESSION 3: NON-INVASIVE BIOMARKERS
Denny Sakkas
, USA
14:30-15:00
Non invasive metabolomic profiling of embryos using spectroscopy
Denny Sakkas, USA
15:00-15:30
Glucose to assess embryo viability and sex
David Gardner, Australia
15:30-16:00
 
Non invasive biomarkers to discriminate embryo aneuploidy
Francisco Domínguez, Spain
 
16:00-16:30
Coffee Break
 
16:30-17:30
Chairperson:
SESSION 4: NEW TECHNOLOGIES “IN PROGRESS”
Lois Salamonsen
, Australia
16:30-17:00
Embryology in the era of proteomics
Mandy Katz-Jaffe, USA
17:00-17:30
Fetal DNA in maternal blood
Brynn Levy, USA (Natera, Inc.)

THE OVARIAN RESERVE, SPERM AND THE ENDOMETRIUM

Saturday, 31 March 2012

09:00-11:00
Chairperson:
SESSION 5: THE OVARIAN RESERVE AND GAMETES
Nick Macklon
, UK
09:00-09:30
Biomarkers of ovarian response
Scott Nelson, UK
09:30-10:00
Polymorphisms as biomarkers of ovarian reserve and oocyte quality
Maria Lalioti, USA
10:00-10:30
Novel technologies for selecting the best sperm for IVF and ICSI
Denny Sakkas, USA
10:30-11:00
Assessment of sperm using microarray technology
Nicolas Garrido, Spain
 
11:00-11:30
Coffee Break
 
11:30-13:30
Chairperson:
SESSION 6: THE ENDOMETRIUM
Carlos Simón
, Spain
11:30-12:00
Profiling the gene signature of endometrial receptivity. Clinical results
Carlos Simón, Spain
12:00-12:30
Proteomics of the human endometrium
Lois Salamonsen, Australia
12:30-13:00
Secretomics of the endometrium
Nick Macklon, UK
13:00-13:30
Q & A
 
13:30-13:45
Technical Break
 
13:45-14:30
LUNCH SYMPOSIUM SPONSORED BY MERCK SERONO
GRANT FOR FERTILITY INNOVATION: DEVELOPING INNOVATIVE TECHNOLOGIES TO BECOME BEST IN CLASS IN TAKE HOME BABY RATE
Lipidomics: A non-invasive diagnostic method of human endometrial receptivity
Carlos Simón
, Spain
   
14:30-15:00
Coffee Break
 
15:00-17:00 
Chairpersons:
SESSION 7: CLINICAL TRANSLATION: THE TRANSLATORS. WHAT COMPANIES ARE IN THE HORIZON? (Part 1)
Denny Sakkas
, USA; Carlos Simón, Spain
15:00-15:15
Morphokinetic embryo analysis – “The Vision to Conceive”
Niels Birger Ramsing, Denmark (Unisense FertiliTech A/S)
15:15-15:30
Getting started with 24sure PGS aneuploidy screening
Graham Snudden, UK (BlueGnome Ltd.)
15:30-15:45 How to Incorporate NIPD into practice
Solomon Moshkevich, USA (Natera, Inc.)
15:45-16:00 A services provider of genetic diagnosis
David Jimenez, Spain (Iviomics, S.L.)


Chairpersons:
SESSION 7: CLINICAL TRANSLATION: THE TRANSLATORS. WHAT COMPANIES ARE IN THE HORIZON? (Part 2)
Denny Sakkas
, USA; Carlos Simón, Spain
16:00-16:40
How will new technologies be introduced and what will be their potential commercial impact?
Diego Ezcurra, USA
16:40-17:00 General Discussion
Chairpersons: David Gardner, Australia; Carlos Simón, Spain


 
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 11/27/2012 Created by     WebStudio.co.il